Skip to content

Labcorp Holdings Inc. (LH) stock: revenue, earnings & dividend

Labcorp Holdings Inc. (LH, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener LH · NYSE Gesundheitswesen US-NC

Key figures

Fiscal year
2025
Revenue
14 bn $
Revenue growth
7.3 %
Revenue growth 5y (p.a.)
-0 %
Net income
877 m $
Net margin
6.3 %
Operating margin
9.9 %
Earnings per share (diluted)
10.46 $
Dividend per share
2.88 $
Payout ratio
27.5 %
Consecutive dividend years
4 years
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
18.4 bn $
Equity
8.62 bn $
Equity ratio
46.9 %
Return on equity
10.2 %
Cash
532 m $
Operating cash flow
1.64 bn $
Free cash flow
1.21 bn $
Shares outstanding
81,200,000

History

Revenue by fiscal year

2016 9.55 bn $
2017 10.3 bn $
2018 11.3 bn $
2019 11.6 bn $
2020 14 bn $
2021 13.1 bn $
2022 11.9 bn $
2023 12.2 bn $
2024 13 bn $
2025 14 bn $

Net income by fiscal year

2016 712 m $
2017 1.23 bn $
2018 884 m $
2019 824 m $
2020 1.56 bn $
2021 2.38 bn $
2022 1.28 bn $
2023 418 m $
2024 746 m $
2025 877 m $

Dividend per share

2022 2.16 $
2023 2.88 $
2024 2.88 $
2025 2.88 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202514 bn $877 m $10.46 $2.88 $1.64 bn $
202413 bn $746 m $8.84 $2.88 $1.59 bn $
202312.2 bn $418 m $4.77 $2.88 $1.33 bn $
202211.9 bn $1.28 bn $13.97 $2.16 $1.96 bn $
202113.1 bn $2.38 bn $24.39 $–3.11 bn $
202014 bn $1.56 bn $15.88 $–2.14 bn $
201911.6 bn $824 m $8.35 $–1.44 bn $
201811.3 bn $884 m $8.61 $–1.31 bn $
201710.3 bn $1.23 bn $11.81 $–1.5 bn $
20169.55 bn $712 m $6.82 $–1.2 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)